David Planchard: Honored to Chair a Brilliant Session on ADCs at KALC2025
David Planchard, a thoracic oncologist and professor at the University Paris-Saclay, as well as the head of the Thoracic Cancer Group at Gustave Roussy, shared his impressions of the KALC2025 meeting.
“Brilliant session on ADCs at the KALC2025 meeting, which I was lucky to chair. Saw a superb, comprehensive overview from Peters Solange on the key points and ICIs. Always a pleasure catching up and exchanging with my Asian colleagues.”
The event gathered leading oncology specialists to discuss advances in antibody-drug conjugates (ADCs) and immune checkpoint inhibitors (ICIs), highlighting global collaboration in cancer research.
About David Planchard
- Thoracic oncologist and professor at the University Paris-Saclay
- Head of the Thoracic Cancer Group at Gustave Roussy
- Active contributor to international cancer research and collaboration
About KALC2025
KALC2025 is an international oncology conference focusing on innovative therapeutic approaches and knowledge exchange among experts across the world.
Author’s summary: David Planchard shared his insights on chairing a notable KALC2025 session on ADCs, emphasizing expertise, collaboration, and innovation in global oncology.